询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Cymiazole | CAS:61676-87-7
Cymiazole
  • 名称:螨蜱胺; N-3-甲基-4-亚噻唑-2-基-2,4-二甲基苯胺 | Cymiazole
  • CAS号:61676-87-7
  • 别名:2,4-Dimethyl-N-(3-methyl-2(3H)-thiazolylidene)benzenamine; N-(3-Methyl-3H-thiazol-2-ylidene)-2,5-xylidine
  • 分子式:C12H14N2S
  • 分子量:218.32
  • EINESC号:262-890-9

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
Sigma-Aldrich 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.Paula B Deming et al.The Journal of biological chemistry, 277(39), 36832-36838 (2002-07-31) Topoisomerase II poisoning by ICRF-193.K C Huang et al.The Journal of biological chemistry, 276(48), 44488-44494 (2001-09-29) The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.B B Hasinoff et al.Molecular pharmacology, 59(3), 453-461 (2001-02-17) Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.Muhammad Sheraz et al.Journal of virology, 93(11) (2019-03-15) The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemiaNiitsu, Experimental Hematology, 30(11), 1273-1282 (2002) Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs.K Iguchi et al.Biochemical pharmacology, 57(10), 1105-1111 (2001-03-07) DNA topoisomerase II is dispensable for oocyte meiotic resumption but is essential for meiotic chromosome condensation and separation in miceLi X M, et al. Biology of Reproduction, 89(5), 1273-1282 (2013) Topoisomerase II Is Crucial for Fork Convergence during Vertebrate Replication Termination.Darren R Heintzman et al.Cell reports, 29(2), 422-436 (2019-10-10) DNA strand breaks induced by the anti-topoisomerase II bis-dioxopiperazine ICRF-193.N Hajji et al.Mutation research, 530(1-2), 35-46 (2003-10-18) ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cellsIwai M, et al. Febs Letters, 406(3), 267-270 (1997)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交